Fulcrum Therapeutics's Earnings Outlook
Fulcrum Therapeutics's Earnings Outlook
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Wednesday, 2024-11-13. Here's what investors need to know before the announcement.
纳斯达克上的fulcrum therapeutics（纳斯达克代码：FULC）定于2024年11月13日（星期三）公布最新季度财报。投资者在公布前需要了解的内容如下。
Analysts estimate that Fulcrum Therapeutics will report an earnings per share (EPS) of $-0.41.
分析师估计fulcrum therapeutics将公布每股收益（EPS）为-0.41美元。
Investors in Fulcrum Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
fulcrum therapeutics的投资者急切期待公司的公告，希望获得超出预期的消息，并为下一个季度提供积极的指引。
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
值得新投资者注意的是，股票价格往往受未来预期的影响，而不仅仅是过去的业绩。
Historical Earnings Performance
历史业绩表现
During the last quarter, the company reported an EPS beat by $0.88, leading to a 2.91% drop in the share price on the subsequent day.
在上个季度，该公司报告的每股收益超出0.88美元，导致股价在随后一天下跌了2.91%。
To track all earnings releases for Fulcrum Therapeutics visit their earnings calendar on our site.
要跟踪fulcrum therapeutics的所有财报发布，请访问我们网站上的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自动内容引擎生成，并由编辑审核。
